Navigation Links
Scientists determine the structure of highly efficient light-harvesting molecules in green bacteria
Date:5/4/2009

An international team of scientists has determined the structure of the chlorophyll molecules in green bacteria that are responsible for harvesting light energy. The team's results one day could be used to build artificial photosynthetic systems, such as those that convert solar energy to electrical energy. A research paper about the discovery will be published on 4 May 2009 in the Proceedings of the National Academy of Sciences.

The scientists found that the chlorophylls are highly efficient at harvesting light energy. "We found that the orientation of the chlorophyll molecules make green bacteria extremely efficient at harvesting light," said Donald Bryant, Ernest C. Pollard Professor of Biotechnology at Penn State and one of the team's leaders. According to Bryant, green bacteria are a group of organisms that generally live in extremely low-light environments, such as in light-deprived regions of hot springs and at depths of 100 meters in the Black Sea. The bacteria contain structures called chlorosomes, which contain up to 250,000 chlorophylls. "The ability to capture light energy and rapidly deliver it to where it needs to go is essential to these bacteria, some of which see only a few photons of light per chlorophyll per day."

Because they have been so difficult to study, the chlorosomes in green bacteria are the last class of light-harvesting complexes to be characterized structurally by scientists. Scientists typically characterize molecular structures using X-ray crystallography, a technique that determines the arrangement of atoms in a molecule and ultimately gives information that can be used to create a picture of the molecule; however, X-ray crystallography could not be used to characterize the chlorosomes in green bacteria because the technique only works for molecules that are uniform in size, shape, and structure. "Each chlorosome in a green bacterium has a unique organization," said Bryant. "They are like lit
'/>"/>

Contact: Barbara K. Kennedy
science@psu.edu
814-863-4682
Penn State
Source:Eurekalert  

Page: 1 2 3 4 5

Related biology technology :

1. Gladstone scientists uncover potential mechanism of memory loss in Alzheimers disease
2. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
3. Social Network for Scientists Marks Ten Years Online
4. Scientists synthesize memory in yeast cells
5. Scientists synthesize memory in yeast cells
6. University of Leicester scientists discover technique to help friendly bacteria
7. Scientists discover how cancer may take hold
8. Yale scientists make 2 giant steps in advancement of quantum computing
9. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
10. Scientists say sabercat bit like a pussycat
11. New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists determine the structure of highly efficient light-harvesting molecules in green bacteria
Scientists determine the structure of highly efficient light-harvesting molecules in green bacteria
(Date:11/24/2009)...sador to also Visit Detroit , ...Appia, French Ambassador for International Investm...Agency, , , , ,What: Ambassador Appia is availabl...s initiatives adopted by France to further develop...innovation and development., , ,When: Available fo...
(Date:11/24/2009)...rio,Nov.24/PRNewswire-FirstCall/--DowAgroSciencesC...eeds,adivisionofThompsonsLimitedofBlenheim,Ontario...ciences,currentseedsbusinessasthecompanyanticipate...groSciencesHerbicideTolerantTraitTechnologyincorni...re. ,, "Thisacquisitionbringstogethertwostrongp...
(Date:11/24/2009)...th care employment grew by 29,000 jobs in October...stent growth during the U.S. recession. However, c...and health systems are coming closer to having to ...ministrators. , (Vocus) N...ed growing in October despite the shedding of jobs...
(Date:11/24/2009)...PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX...commercializingnovelpainmanagementtherapies,announ...iveOfficer,isscheduledtopresentatthe21stAnnualPipe...009atTheNewYorkPalaceHotelinNewYork,NewYork. ,,...er,willbeavailabletorespondtoquestionsduringthepre...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...., Jan. 13 Nektar Therapeutics,(Nasdaq: NKTR ) ... 2 clinical,trial of NKTR-102 in platinum-resistan...been obtained and dosing will begin shortly in two...evaluate NKTR-102 versus irinotecan in,second-line...ation, and a,Phase 2 study in metastatic breast ca...
.... 13 Burnham Institute for Medical Research (Burn...greement with Johnson & Johnson Pharmaceutical...he agreement is Burnham,s first broad-based partne...der this multi-year agreement, Burnham will provid...screening technologies to investigate certain drug...
...., Jan. 13 Neurobiological,Technologies, Inc. (Na...owing a,detailed analysis of the recent interim re...any has decided not to develop Viprinex further fo... was recently studied in a,clinical trial to deter...,outcome when given within six hours of a stroke, ...
Other Biology Technology:First Patient Dosed in Phase 2 Clinical Trial of NKTR-102 in Ovarian Cancer 2First Patient Dosed in Phase 2 Clinical Trial of NKTR-102 in Ovarian Cancer 3First Patient Dosed in Phase 2 Clinical Trial of NKTR-102 in Ovarian Cancer 4Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2Neurobiological Technologies Announces Suspension of Viprinex Development 2Neurobiological Technologies Announces Suspension of Viprinex Development 3
(Date:11/25/2009)...ach, may be used to boost resistance to, or slow, ...l of Medicine researchers report in a study publis...nce . , Parkinson,s disease is caused by a degen...rain known as the substantia nigra, which is respo...n of dopamine in late-stage Parkinson,s causes sym...
(Date:11/25/2009)...eath Research Laboratory in the University of Haif...estigious Johnson & Johnson Focused Funding grant ... damage in Parkinson,s disease. The award, which i...novation and excellence in science, was announced ...th at an event at the Hyatt Regency Hotel in New J...
(Date:11/25/2009)...fessors recently received funding from the Nationa...neficial to understanding the environment. The thr...d, assistant professor in the Department of Biolog...eparate research projects. , His first project, ...nd Functions from the Leaf to the Landscape," will...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Kent State University professors focus research on the environment with grants totaling $890,000 2Rigel to Present at Jefferies Healthcare Conference 48415 1AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 1AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 2AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 3AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 4AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 5Oramed Pharmaceuticals to Present at the 8th National Life Science 26 Technology Week ILSI BIOMED Conference Israel 2009 4583 1Oramed Pharmaceuticals to Present at the 8th National Life Science 26 Technology Week ILSI BIOMED Conference Israel 2009 4583 2
... subjects to operate a robot-controlled joystick, ...er the brain "learns" to control certain muscle mo...son over the long haul. The results, the investiga...r people who have lost motor abilities to brain in... the May 23 issue of PLoS Biology, the researchers...
...archers have found a group of cells in the intesti...lls, cells that help fight infection. , The resear...journal Immunity, released today. , "This connect... will help in studying and developing treatments f...m," said Stephen McSorley, Ph.D., professor of med...
...t four factors, researchers have successfully indu...or adult mice to behave like embryonic stem cells....ediate early publication of the journal Cell, publ...rchers designate "induced pluripotent stem cells" ...haracteristics typical of embryonic stem cells, th...
Other Biology News:New approach to vaccine development provides potent, long-lasting immunity 2New approach to vaccine development provides potent, long-lasting immunity 3With few factors, adult cells take on character of embryonic stem cells 2
Mouse Anti-Mouse Qa-2 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone 695H1-9-9 from BioLegend
27-mer duplex from B-Bridge International
Propidium Iodide Buffer from BioLegend
Luminex 100 Instrument System from Upstate
Biology Products: